Gary Greenwald
Rancho Mirage, CANPI 1093797151
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$593,887in research payments, 2019–2025
Across 64 payments — averaging $9279.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$383K
- Pfizer$189K
- Genentech, Inc.$23K
- Novartis$96
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.